| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  trans-Tranilast | Tranilast | IC50 | > | 10 | uM | ALA4423718 | nM | Homo sapiens | |||
| 2. |  SET 2 | 2 | INH | 0 | ALA4423738 | Active | % | Homo sapiens | ||||
| 3. |  Mavatrep | MAVATREP | Activity | 0 | ALA3429461 | Not Active | Homo sapiens | |||||
| 4. |  GFB-8438 | GFB-8438 | INH | 0 | ALA4411005 | Not Active | % | Homo sapiens | ||||
| 5. |  cannabichromene | 10 | IC50 | = | 6.5 | uM | ALA5096628 | 5.19 | nM | Homo sapiens | ||
| 6. |  ALA4170268 | 1b; CBV | IC50 | = | 2.2 | uM | ALA5096628 | 5.66 | nM | Homo sapiens | ||
| 7. |  ALA74415 | 2 | IC50 | = | 15.7 | uM | ALA5096628 | 4.80 | nM | Homo sapiens | ||
| 8. |  Cannabigerol | 3b, cbg | IC50 | = | 1.5 | uM | ALA5096628 | 5.82 | nM | Homo sapiens | ||
| 9. |  Cannabidivarin | 9 | IC50 | = | 31 | uM | ALA5096628 | 4.51 | nM | Homo sapiens | ||
| 10. |  tetrahydrocannabivarin | 8 | IC50 | = | 0.8 | uM | ALA5096628 | 6.10 | nM | Homo sapiens | ||
| 11. | cannabichromene | 10 | Efficacy | < | 10 | % | ALA5096627 | % | Homo sapiens | |||
| 12. | ALA4170268 | 1b; CBV | Efficacy | = | 79 | % | ALA5096627 | % | Homo sapiens | |||
| 13. | ALA74415 | 2 | Efficacy | = | 74 | % | ALA5096627 | % | Homo sapiens | |||
| 14. | Cannabigerol | 3b, cbg | Efficacy | = | 74 | % | ALA5096627 | % | Homo sapiens | |||
| 15. | Cannabidivarin | 9 | Efficacy | = | 50 | % | ALA5096627 | % | Homo sapiens | |||
| 16. | tetrahydrocannabivarin | 8 | Efficacy | = | 74 | % | ALA5096627 | % | Homo sapiens | |||
| 17. | ALA4170268 | 1b; CBV | EC50 | = | 3.1 | uM | ALA5096626 | 5.51 | nM | Homo sapiens | ||
| 18. | ALA74415 | 2 | EC50 | = | 19 | uM | ALA5096626 | 4.72 | nM | Homo sapiens | ||
| 19. | Cannabigerol | 3b, cbg | EC50 | = | 1.7 | uM | ALA5096626 | 5.77 | nM | Homo sapiens | ||
| 20. | Cannabidivarin | 9 | EC50 | = | 7.3 | uM | ALA5096626 | 5.14 | nM | Homo sapiens |
The page will load shortly, Thanks for your patience!